• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Itsuro Morishima, Takahito Sone, +7 authors Tetsuo Hayakawa
  • Medicine
  • Journal of the American College of Cardiology
  • 2000 (First Publication: 1 October 2000)
  • OBJECTIVES We sought to elucidate the long-term prognostic importance of angiographic no-reflow phenomenon after percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarctionContinue Reading
  • Itsuro Morishima, Takahito Sone, +6 authors Hiromi Sassa
  • Medicine
  • American heart journal
  • 1995 (First Publication: 1 August 1995)
  • The clinical significance of the angiographic no-reflow phenomenon was evaluated in 93 patients with acute myocardial infarction treated by percutaneous transluminal coronary angioplasty (PTCA). OnContinue Reading
  • Yasushi Numaguchi, Takahito Sone, +9 authors Toyoaki Murohara
  • Medicine
  • Circulation
  • 2006 (First Publication: 4 July 2006)
  • BACKGROUND Circulating endothelial progenitor cells (EPCs) are known to be involved in vasculogenesis and mobilized after acute myocardial infarction (AMI). To test the hypothesis that the angiogenicContinue Reading
  • Katsumasa Takagi, Yoshiji Yamada, Jian-Sheng Gong, Takahito Sone, Mitsuhiro Yokota, Masashi Tanaka
  • Biology, Medicine
  • Atherosclerosis
  • 2004 (First Publication: 1 August 2004)
  • Because mitochondria are the major sources of reactive oxygen species (ROS) in cells, certain alterations in mitochondrial functions can lead to metabolic perturbation in vascular endothelial cellsContinue Reading
  • Takashi Muramatsu, Kunihiro Matsushita, +9 authors Toyoaki Murohara
  • Medicine
  • Hypertension
  • 2012 (First Publication: 1 March 2012)
  • It has not been fully examined whether angiotensin II receptor blocker is superior to calcium channel blocker to reduce cardiovascular events in hypertensive patients with glucose intolerance. AContinue Reading